Sentry BioPharma Services ApS: Financial statements 2025
CVR: 41330619
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Sentry BioPharma Services ApS (CVR 41330619) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK -537,511 compared with DKK -3,275,518 the year before. Equity in the 2025 report amounted to DKK -11,627,396.
- Profit/Loss
- DKK -537,511
- Equity
- DKK -11,627,396
- Total Assets
- DKK 14,599,431
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | -538 t. | -11.6 mio. | 0 |
| 2024 | - | - | -3.3 mio. | -11.1 mio. | - |
| 2023 | - | - | -3.6 mio. | -7.8 mio. | - |
| 2022 | - | - | -2.8 mio. | -4.2 mio. | - |
| 2021 | - | - | -1.1 mio. | -1.4 mio. | - |
Official annual report
How creditworthy is Sentry BioPharma Services ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Sentry BioPharma Services ApS has published its annual report for 2024. The net result was DKK -3,275,518.
About Sentry BioPharma Services ApS
Sentry BioPharma Services ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Oplagring og opbevaring. The management consists of Timothy Jon Mitchell and William Maxwell Tuttle. The company is owned by Sentry BioPharma Services, Inc.. The company has 1 employee (2026). In 2025, the company reported a net result of DKK -537,511 compared with DKK -3,275,518 the year before. Equity in the 2025 report amounted to DKK -11,627,396.